Found 170 matching trials
Safety and Efficacy of Anti-CD47, ALX148 in Combination With Liposomal Doxorubicin and Pembrolizumab in Recurrent Platinum-resistant Ovarian Cancer PHASE2 Immunotherapy with immune checkpoint inhibitors, including pembrolizumab, h...
Show More Status
Active Not Recruiting
Location
UPMC Hillman Cancer Center
Learn More & Join Trial
Reprab Study: PLD + Trabectedin Rechallenge PHASE2 RECHALLENGE WITH PEGYLATED LIPOSOMAL DOXORUBICIN ADDED TO TRABECTEDIN IN RE...
Show More Location
Fondazione Policlinico Gemelli IRCCS
Learn More & Join Trial
Efficacy and Safety of Neoadjuvant DC-T in Breast Cancer Patients PHASE4 This is a multicentric, open-label,non-randomized concurrent control, 1:1 m...
Show More Learn More & Join Trial
An uMbrella Study of BIomarker-driven Targeted Therapy In Patients With Platinum-resistant Recurrent OvariaN Cancer(AMBITION) PHASE2 This study is a pilot study of biomarker-driven targeted therapy in patient...
Show More Location
Seoul National University Hospital
Learn More & Join Trial
Clinical Trial of Chemotherapy, Oregovomab and Nivolumab in Patients With Epithelial Cancer of Ovarian, Tubal or Peritoneal Origin PHASE1 This is an open-label, single-arm, phase I/II, single-center study with dos...
Show More Location
National University Hospital
Learn More & Join Trial
A Study of Carboplatin and DOXIL Plus Bevacizumab in Patients With Platinum Sensitive Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Cancers PHASE2 The purpose of this study is to evaluate the response rate (Complete Respon...
Show More Location
Multiple Locations
Learn More & Join Trial
Pomalidomide, Dexamethasone and Pegylated Liposomal Doxorubicin for Relapsed/Refractory Multiple Myeloma PHASE1 The purpose of this clinical research study is to evaluate the safety and e...
Show More Location
Roy and Patricia Disney Family Cancer Center
Learn More & Join Trial
PLD Combined With Cisplatin in the Treatment of Advanced Poorly Differentiated Thyroid Carcinoma PHASE2 This is a prospective, multicenter, open label Phase II Clinical Trial. 30 ...
Show More Location
Zhejiang Cancer Hospital
Learn More & Join Trial
Metronomic PLD in Patients With Primary Endocrine Resistant ABC PHASE2 Metronomic PLD in Patients with Primary Endocrine Resistant ABC...
Location
Fudan University Cancer Hospital
Learn More & Join Trial
Retrospective Study to Analyze the Efficacy and Safety of Trabectedin and Pegylated Liposomal Doxorubicin (PLD ) in the Treatment of Patients With Platinum-sensitive Recurrent Ovarian Cancer (ROC), According to SmPC N/A Retrospective Study to Analyze the Efficacy and Safety of Trabectedin and P...
Show More Location
Multiple Locations
Learn More & Join Trial